UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
-----------------------------
Date of Report (Date of earliest event reported): August 18, 2003
Orthofix International N.V.
(Exact name of Registrant as specified in its charter)
Netherlands Antilles 0-19961 N/A
(State or other jurisdiction Commission (I.R.S. Employer
of incorporation) File Number Identification Number)
-----------------------------
7 Abraham de Veerstraat
Curacao
Netherlands Antilles
011-59-99-465-8525
(Address of principal executive offices and telephone number,
including area code)
-----------------------------
Item 5. Other Events and Regulation FD Disclosure.
-----------------------------------------
On August 18, 2003, Orthofix International N.V. ("Orthofix") issued a
press release announcing the settlement of a government investigation regarding
off-label use of its external bone growth stimulator. A copy of the press
release is attached hereto as Exhibit 99.1 and is incorporated by reference
herein.
Exhibit
-------
99.1 Press release of Orthofix International N.V. dated August 18, 2003
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Dated: August 19, 2003
ORTHOFIX INTERNATIONAL N.V.
By: /s/ Thomas Hein
------------------------------
Name: Thomas Hein
Title: Chief Financial Officer